Brazil - Anvisa Draft Update in the Regulation for Risk Classification, Notification, Registration and Registration Control Regimes, Labeling Requirements and Instructions for Use of In Vitro Diagnostic Medical Devices, Including Their Instruments.
Business description
The Brazilian Health Regulatory Agency (Anvisa) issued the Public Consultation No. 734 of October 22, 2019, to update the regulation for risk classification, notification, registration and registration control regimes, labeling requirements and instructions for use of in vitro diagnostic medical devices, including their instruments according to Anvisa Resolution RDC No 36 of August 26, 2015.
Contributions are accepted by filling in the specific form in the Anvisa Public Consultation Contributions link between October 30 and December 30, 2019.
Countries:
Brazil
Technical aspects:
Labeling and Packaging
Safety
Regions:
South-America
Disclaimer
The content of our website has been compiled with meticulous care and to the best of our knowledge. However, we cannot assume liability on the page content to be up-to-date, complete or accurate.